Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9GE3

Structure of GPR55 in complex with G13 and endogenous lipid agonist lysophosphatidylinositol

This is a non-PDB format compatible entry.
Summary for 9GE3
Entry DOI10.2210/pdb9ge3/pdb
EMDB information51288
DescriptorGuanine nucleotide-binding protein subunit alpha-13, Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1, Single-chain variable fragment ScFv16, ... (8 entities in total)
Functional Keywordsg protein-coupled receptor, gpcr, lipid agonist, cholesterol, membrane protein
Biological sourceHomo sapiens (human)
More
Total number of polymer chains5
Total formula weight175486.12
Authors
Claff, T.,Ebenhoch, R.,Weichert, D. (deposition date: 2024-08-06, release date: 2025-03-05)
Primary citationClaff, T.,Ebenhoch, R.,Kley, J.T.,Magarkar, A.,Nar, H.,Weichert, D.
Structural basis for lipid-mediated activation of G protein-coupled receptor GPR55.
Nat Commun, 16:1973-1973, 2025
Cited by
PubMed Abstract: GPR55 is an orphan G protein-coupled receptor (GPCR) and represents a promising drug target for cancer, inflammation, and metabolic diseases. The endogenous activation of lipid GPCRs can be solely mediated by membrane components and different lipids have been proposed as endogenous activators of GPR55, such as cannabinoids and lysophosphatidylinositols. Here, we determine high-resolution cryo-electron microscopy structures of the activated GPR55 in complex with heterotrimeric G and two structurally diverse ligands: the putative endogenous agonist 1-palmitoyl-2-lysophosphatidylinositol (LPI) and the synthetic agonist ML184. These results reveal insights into ligand recognition at GPR55, G protein coupling and receptor activation. Notably, an orthosteric binding site opening towards the membrane is observed in both structures, enabling direct interaction of the agonists with membrane lipids. The structural observations are supported by mutagenesis and functional experiments employing G protein dissociation assays. These findings will be of importance for the structure-based development of drugs targeting GPR55.
PubMed: 40000629
DOI: 10.1038/s41467-025-57204-y
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (2.87 Å)
Structure validation

232418

PDB entries from 2025-03-05

PDB statisticsPDBj update infoContact PDBjnumon